Insight Molecular Diagnostics Inc.
IMDX· Nasdaq
IMDXInsight Molecular Diagnostics Inc.
Filed Mar 24, 2025 · 10-K · 83 days after period end · 0000950170-25-043852
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $1.49M | $314.00K | $274.00K | $3.59M |
| Net Income | -$33.51M | -$15.99M | -$44.98M | -$35.89M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 24, 2025 · 83 d after period end
